BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29614360)

  • 1. Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas.
    Yasuda T; Muragaki Y; Nitta M; Miyamoto K; Oura Y; Henmi T; Noguchi S; Oda H; Saito T; Maruyama T; Atsuchi S; Miura N; Kawamata T
    World Neurosurg; 2018 Jun; 114():e1138-e1146. PubMed ID: 29614360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
    Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
    Shapiro LQ; Beal K; Goenka A; Karimi S; Iwamoto FM; Yamada Y; Zhang Z; Lassman AB; Abrey LE; Gutin PH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):636-42. PubMed ID: 22765876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas - A Pilot Study.
    Shiba H; Takeuchi K; Hiramatsu R; Furuse M; Nonoguchi N; Kawabata S; Kuroiwa T; Kondo N; Sakurai Y; Suzuki M; Ono K; Oue S; Ishikawa E; Michiue H; Miyatake SI
    Neurol Med Chir (Tokyo); 2018 Dec; 58(12):487-494. PubMed ID: 30464150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
    J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
    Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
    Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
    Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
    Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial.
    Cabrera AR; Cuneo KC; Desjardins A; Sampson JH; McSherry F; Herndon JE; Peters KB; Allen K; Hoang JK; Chang Z; Craciunescu O; Vredenburgh JJ; Friedman HS; Kirkpatrick JP
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):873-9. PubMed ID: 23725997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control.
    Ogura K; Mizowaki T; Arakawa Y; Sakanaka K; Miyamoto S; Hiraoka M
    Cancer Med; 2013 Dec; 2(6):942-9. PubMed ID: 24403268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
    Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
    Fogh SE; Andrews DW; Glass J; Curran W; Glass C; Champ C; Evans JJ; Hyslop T; Pequignot E; Downes B; Comber E; Maltenfort M; Dicker AP; Werner-Wasik M
    J Clin Oncol; 2010 Jun; 28(18):3048-53. PubMed ID: 20479391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation and bevacizumab in high-grade glioma retreatment settings.
    Niyazi M; Ganswindt U; Schwarz SB; Kreth FW; Tonn JC; Geisler J; la Fougère C; Ertl L; Linn J; Siefert A; Belka C
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):67-76. PubMed ID: 21030162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
    McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
    J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of stereotactic radiotherapy as salvage treatment for recurrent malignant gliomas.
    Ekici K; Ozseker N; Mayadagli A; Erdogan Kocak M; Olmezoglu A
    J BUON; 2014; 19(4):1029-34. PubMed ID: 25536612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.
    Bovi JA; Prah MA; Retzlaff AA; Schmainda KM; Connelly JM; Rand SD; Marszalkowski CS; Mueller WM; Siker ML; Schultz CJ
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):979-986. PubMed ID: 32599030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.
    Yonezawa H; Ohno M; Igaki H; Miyakita Y; Takahashi M; Tamura Y; Shima S; Matsushita Y; Ichimura K; Narita Y
    Jpn J Clin Oncol; 2021 Jul; 51(7):1028-1035. PubMed ID: 33959771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.
    Shi W; Palmer JD; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Bar-Ad V; Judy K; Farrell C; Simone N; Liu H; Dicker AP; Lawrence YR
    J Neurooncol; 2016 May; 127(3):535-9. PubMed ID: 26821711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
    Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
    Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.
    Shepherd SF; Laing RW; Cosgrove VP; Warrington AP; Hines F; Ashley SE; Brada M
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):393-8. PubMed ID: 9069312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L; Falkov A; Chelimo C; Fogh SE
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.